Effective exosomes reduction in hypercholesterinemic patients suffering from cardiovascular diseases by lipoprotein apheresis: Exosomes apheresis

被引:0
|
作者
Schroeder, Sophie [1 ]
Epple, Robert [1 ]
Fischer, Andre [1 ,2 ,3 ]
Schettler, Volker J. J. [4 ,5 ]
机构
[1] German Ctr Neurodegenerat Dis DZNE Gottingen, Dept Epigenet & Syst Med Neurodegenerat Dis, Gottingen, Germany
[2] Univ Med Ctr Gottingen, Dept Psychiat & Psychotherapy, Gottingen, Germany
[3] Univ Gottingen, Cluster Excellence Multiscale Bioimaging Mol Machi, Gottingen, Germany
[4] Ctr Nephrol Gottingen GbR, Gottingen, Germany
[5] Nephrol Zentrum Gottingen GbR, An der Lutter 24, D-37075 Gottingen, Germany
关键词
coronary heart disease; exosomes; hemodialysis; lipoprotein apheresis; risk reduction; EXTRACELLULAR VESICLES; ATHEROSCLEROSIS; MICROPARTICLES; RISK;
D O I
10.1111/1744-9987.14172
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionExtracellular vesicles (EVs) have been identified as playing a role in atherosclerosis.MethodsA group of 37 hypercholesterolemic patients with atherosclerotic cardiovascular diseases (ASCVD) and 9 patients requiring hemodialysis (HD) were selected for the study.ResultsEVs were comparably reduced by various LA methods (Thermo: 87.66% +/- 3.64, DALI: 87.96% +/- 4.81, H.E.L.P.: 83.38% +/- 11.98; represented as SEM). However, LDL-C (66%; 55%; 75%) and Lp(a) (72%; 67%; 79%) were less effectively reduced by DALI. There was no significant difference in the reduction of EVs when comparing different techniques, such as hemoperfusion (DALI; n = 13), a precipitation (H.E.L.P.; n = 5), and a double filtration procedure (Thermofiltration; n = 19). Additionally, no effect of hemodialysis on EVs reduction was found.ConclusionsThe study suggests that EVs can be effectively removed by various LA procedures, and this effect appears to be independent of the specific LA procedure used, as compared to hemodialysis.
引用
收藏
页码:863 / 870
页数:8
相关论文
共 50 条
  • [1] Lipoprotein apheresis in Austria - Reduction of cardiovascular events by regular lipoprotein apheresis treatment
    Berent, Theresa
    Derfler, Kurt
    Berent, Robert
    Sinzinger, Helmut
    ATHEROSCLEROSIS SUPPLEMENTS, 2019, 40 : 8 - 11
  • [2] Role of Lipoprotein Apheresis in Cardiovascular Disease Risk Reduction
    Raina, Rupesh
    Young, Claire
    Krishnappa, Vinod
    Chanchlani, Rahul
    BLOOD PURIFICATION, 2019, 47 (04) : 301 - 316
  • [3] Highly Effective Influencing cardiovascular Risk factors by means of Lipoprotein Apheresis
    Fischer, S.
    von Dryander, M.
    Passauer, J.
    Mueller, G.
    Bornstein, S.
    Julius, U.
    INTERNIST, 2013, 54 : 81 - 81
  • [4] Factors inducing cardiovascular events in patients treated by lipoprotein apheresis
    Taseva, K.
    Fischer, S.
    Passauer, J.
    Weiss, N.
    Bornstein, S. R.
    Julius, U.
    ATHEROSCLEROSIS SUPPLEMENTS, 2013, 14 (01) : 45 - 50
  • [5] Fatty acid analysis in serum of patients with elevated lipoprotein(a) and cardiovascular disease undergoing lipoprotein apheresis
    Mickiewicz, Agnieszka
    Marlega-Linert, Joanna
    Czapiewska, Monika
    Marcinkowska, Marta
    Krzesinska, Aleksandra
    Kuchta, Agnieszka
    Fijalkowski, Marcin
    Gruchala, Marcin
    Mika, Adriana
    JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (02) : e197 - e206
  • [6] CARDIOVASCULAR EVENTS IN PATIENTS TREATED BY LIPOPROTEIN APHERESIS (LA) - ANALYSIS OF POSSIBLE REASONS
    Tselmin, S.
    Fischer, S.
    Pistrosch, F.
    Mueller, G.
    Julius, U.
    ATHEROSCLEROSIS, 2016, 252 : E215 - E216
  • [7] Cardiovascular events in patients with familial hypercholesterolemia and hyperlipoproteinaemia (a): Indications for lipoprotein apheresis in Poland
    Mickiewicz, Agnieszka
    Marlega, Joanna
    Kuchta, Agnieszka
    Bachorski, Witold
    Cwiklinska, Agnieszka
    Raczak, Grzegorz
    Gruchala, Marcin
    Fijalkowski, Marcin
    JOURNAL OF CLINICAL APHERESIS, 2021, 36 (03) : 370 - 378
  • [8] Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?
    Julius, Ulrich
    Kuss, Solveig
    Tselmin, Sergey
    Schatz, Ulrike
    Bornstein, Stefan R.
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2020, 7 (03) : 1 - 9
  • [9] A Bibliometric Analysis of Exosomes in Cardiovascular Diseases From 2001 to 2021
    Ma, Dan
    Guan, Baoyi
    Song, Luxia
    Liu, Qiyu
    Fan, Yixuan
    Zhao, Lin
    Wang, Tongxin
    Zhang, Zihao
    Gao, Zhuye
    Li, Siming
    Xu, Hao
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [10] Roles of Exosomes Derived From Immune Cells in Cardiovascular Diseases
    Wu, Runda
    Gao, Wei
    Yao, Kang
    Ge, Junbo
    FRONTIERS IN IMMUNOLOGY, 2019, 10